… Laparoscopy has proven to be a reliable method for exploring peritoneal carcinomatosis
in selected cases of advanced-stage ovarian cancer. For this purpose, specific scores have …

… 37 patients was analyzed with contrast enhanced abdominal … to assess results of the Peritoneal
Carcinomatosis Index (PCI) … peritoneal metastases in patients with ovarian cancer [3, 26]. …

… The purpose of the study was to evaluate the security, effectiveness, and cytoreduction
optimization of intraperitoneal paclitaxel administration previously to radical surgery/…

… Between January 2014 and March 2018, 90 primary ovarian cancer patients underwent …
for assessment of peritoneal carcinomatosis were assessed. None of those patients received …

… decisional algorithm, including different medical specialties allows optimization of care. …
both lobes of the liver; 1 patient had a severe bulky carcinomatosis of the small bowel. The final 6 …

… patients treated between 1998 and 2007 received NCCN guideline adherent care for ovarian
cancer (adherent care … for the diagnosis of epithelial ovarian cancer). The opportunity costs …

… 13.4 months), and the preoperative tumor burden recorded in peritoneal carcinomatosis
index (PCI) scores was described as an independent prognostic factor, with a significantly …

… test with which ovarian cancer is detected in the US [14], and peritoneal metastases can …
peritoneal carcinomatosis index (CT-PCI) [15, 16]. Most patients with advanced ovarian cancer …

… of ovarian cancer to one employing carboplatin. During this period, the most popular front-line
regimen for the treatment of ovarian cancer … ovarian carcinoma: a North Thames Ovary …

… As a result, the standardization and optimization of the … , fallopian tube carcinoma, and
primary peritoneal carcinoma (… every 3 weeks in patients with advanced ovarian cancer (MITO-7): …